Brace for nonstop Dem hearings, West Bank borders that aren’t and other commentary

Résumé détaillé
Rep. Robert Garcia, incoming House Oversight chair, has “revealed the first targets of what promises to be two years of intense anti-Trump investigations,” notes the Washington…
Rep. Robert Garcia, incoming House Oversight chair, has “revealed the first targets of what promises to be two years of intense anti-Trump investigations,” notes the Washington Examiner’s Byron York. The “highly partisan” probes will focus on “Trump figures” who’ve “enriched themselves” or “been involved in policy initiatives that Democrats find objectionable” or, “even tangentially, in the Jeffrey Epstein matter.” Some parts of the hearings, like “Trump family enrichment,” may be “legitimate, but others,” like targeting Stephen Miller as the “architect” of human-rights abuses, will be “plain old politics.” After all, “the foundation of the Trump immigration crackdown is U.S.
UK foreign minister Ed Miliband, “who likes to remind the public that he is Jewish any time he sides with the enemies of the Jewish state,” imposed sanctions on companies outside “green line Israel,” meaning the West Bank, reports Commentary’s Seth Mandel. But the “green line” is a “fiction” and “does not demarcate legal borders”; rather, it is “explicitly, statutorily not a border” but an “armistice line” where the “the two sides stopped fighting” in 1948.
“Our government is rewarding failure and making its citizens shoulder the cost,” blasts RealClear Politics’ Darin Gaub over Washington’s juicy contracts with Oracle. After failing to fulfill a “10-year, $10 billion contract” to “modernize veterans’ medical records,” in a system that contributed to “the deaths of four veterans,” Oracle won another $17 billion and three more years on its contract — never mind warnings that costs could “balloon” to $50 billion.
Throughout four decades as a science writer, fumes Matt Ridley at The Telegraph, “I have never seen an alleged case of scientific malpractice as influential” as Nature Medicine’s 2020 paper on COVID’s origins.
Début de l'article, extrait de New York Post. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (nypost.com)




